Literature DB >> 34788654

Recurrent ventricular fibrillation induced from supraventricular tachycardia in a case of hypertrophic cardiomyopathy.

Koushik Dasgupta1, Anunay Gupta2, Debdatta Majumdar1, Debabrata Bera3.   

Abstract

Entities:  

Keywords:  AVRT; Concealed accessory pathway; Hypertrophic cardiomyopathy; Supraventricular tachycardia; Ventricular fibrillation

Year:  2021        PMID: 34788654      PMCID: PMC8981144          DOI: 10.1016/j.ipej.2021.11.004

Source DB:  PubMed          Journal:  Indian Pacing Electrophysiol J        ISSN: 0972-6292


× No keyword cloud information.

Discussion

A 45-year-old lady with apical hypertrophic cardiomyopathy (HCM) having good biventricular systolic function underwent implantable cardioverter defibrillator (ICD) implantation 3 years back for secondary prevention. Earlier, she received few anti-tachycardia pacing (ATP) therapies for monomorphic VT in the first year. Subsequently, she did well for the next 2 years on oral sotalol. This time, she was presented to out-patient-clinic with an episode of ICD shock. There was no preceding dizziness or blackout. Device interrogation revealed appropriate therapy for ventricular fibrillation (VF) [Fig. 1]. However, the onset of the VF was very unique. The tachycardia episode started with a premature atrial complex (PAC). As per the V = A branch with good morphology match and chamber of onset (atrium), the diagnosis was correctly made as SVT. However, at 38 seconds the tachycardia degenerated to VF and received an appropriate shock (15 J) at 44 seconds. Oral Amiodarone was started to prevent her SVT suspecting it as atrial tachycardia in the background of HCM. However, within the next 20 days there were several recurrences of the SVT and 2 of those episodes degenerated into VF very similarly. Hence, she was taken up for electrophysiology study which surprisingly revealed a concealed left lateral accessory pathway (AP) with orthodromic AVRT (ORT). The AP was successfully ablated.
Fig. 1

A: Shows onset of the arrhythmia episode. It starts with a PAC (6th beat) and PR interval prolongation.

B: The tachycardia continues with 1:1 A:V relation and is initially diagnosed as SVT. Eventually a VF is induced at the termination of SVT. Similar VF induction was noted in all events requiring ICD shock.

C: A 15 J shock (HV) is delivered from ICD and the VF gets successfully terminated.

A: Shows onset of the arrhythmia episode. It starts with a PAC (6th beat) and PR interval prolongation. B: The tachycardia continues with 1:1 A:V relation and is initially diagnosed as SVT. Eventually a VF is induced at the termination of SVT. Similar VF induction was noted in all events requiring ICD shock. C: A 15 J shock (HV) is delivered from ICD and the VF gets successfully terminated. Induction of VF from atrial tachycardia/atrial fibrillation in HCM is rare but reported [[1], [2], [3]]. Rapid atrial pacing can also induce VF in a subset of HCM [4]. A complex interplay of various electrophysiological and ischemic mechanisms is contemplated for this kind of VF induction [1,4]. There are occasional reports of polymorphic VT from other SVT without any overt structural heart disease [5]. There is an association of pre-excitation syndrome and HCM specially in the subset of PRKAG2 mutation [6,7]. But to the best of our knowledge, the occurrence of VF from ORT has never been reported. This interesting case highlights the importance of careful analysis of stored electrograms so that curative options can be offered.

Funding

None.

Data availability statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Declaration of competing interest

None. Consent has been taken from the patient.
  6 in total

1.  Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?

Authors:  Kenneth M Stein; David E Euler; Rahul Mehra; Karlheinz Seidl; David J Slotwiner; Suneet Mittal; Steven M Markowitz; Bruce B Lerman
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

2.  Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.

Authors:  Mark S Link; Katy Bockstall; Jonathan Weinstock; Alawi A Alsheikh-Ali; Christopher Semsarian; N A Mark Estes; Paolo Spirito; Tammy S Haas; Ethan J Rowin; Martin S Maron; Barry J Maron
Journal:  J Cardiovasc Electrophysiol       Date:  2017-03-31

3.  Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy.

Authors:  M López Gil; F Arribas; F G Cosío
Journal:  Europace       Date:  2000-10       Impact factor: 5.214

Review 4.  PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.

Authors:  Michael H Gollob; Martin S Green; Anthony S L Tang; Robert Roberts
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

5.  Pre-excitation syndrome and hypertrophic cardiomyopathy.

Authors:  A M Perosio; L D Suarez; A M Bunster; A Locreille; O A Apkarian; M A Vallazza; R Foye
Journal:  J Electrocardiol       Date:  1983-01       Impact factor: 1.438

6.  Supraventricular tachycardia triggering polymorphic ventricular tachycardia.

Authors:  Ad W G J Oomen; Bart Hooft van Huysduynen; Raymond W Sy
Journal:  HeartRhythm Case Rep       Date:  2019-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.